class action lawsuit

Law firm Johnson Fistel launches securities investigation into Claritev after 45% stock decline following disappointing 2025 financial results disclosure.

Ardent Health faces class action lawsuit over inflated receivables and delayed loss recognition. Stock dropped 34% after $43M revenue restatement; investors have until March 9 to join.

NuScale Power faces securities lawsuit for allegedly failing to disclose material risks tied to its ENTRA1 partnership, which resulted in a $495 million payment obligation and significant stock decline.

Inovio Pharmaceuticals faces class action lawsuit over alleged false statements regarding manufacturing defects and regulatory prospects after FDA rejected accelerated approval, causing 24% stock decline.

Apollo Global Management faces legal investigation over undisclosed Jeffrey Epstein business relationship, contradicting prior public statements and raising investor disclosure concerns.

Law firm Pomerantz investigates Capital One for potential securities violations following disappointing Q4 earnings and 7.56% stock decline.

Agilon Health faces class action lawsuit over false 2025 financial guidance. Lead plaintiff deadline set for March 2, 2026; eligible investors urged to apply.

Pomerantz Law Firm investigates Atlassian for potential securities violations after Citigroup downgraded the stock due to growth concerns and AI competition threats.

Law firm investigates Ralliant's $1.4B goodwill impairment on EA Elektro-Automatik acquisition. Stock plummeted 31.79% amid scrutiny over disclosure adequacy and valuation assumptions.

BlackRock TCP Capital faces class action lawsuit over NAV understatement and portfolio valuation discrepancies. Investor deadline to join is April 6, 2026.

Pomerantz Law Firm sues Agilon Health for securities fraud following CEO resignation and 51% stock decline after guidance suspension.

Class action filed against BellRing for allegedly misrepresenting sales growth through customer inventory buildup. Stock fell 33% after weaker-than-expected 2025 outlook disclosure.

Pomerantz Law Firm investigates Pharming Group after FDA rejects pediatric drug application, causing 17% stock decline. Inquiry focuses on whether regulatory risks were adequately disclosed to investors.

Law firm investigates Franklin BSP Realty Trust for potential securities violations after missing earnings expectations and reporting significant asset liquidation delays, triggering a 14% stock decline.

Masonite shareholders can join a class action lawsuit until April 2026, alleging the company hid acquisition proposals while conducting stock buybacks, harming investors.

Smart Digital Group faces class action lawsuit after 86% stock decline and NASDAQ trading suspension. Investors have until March 16, 2026 deadline to join.

Pomerantz LLP sues Ardent Health for securities fraud over November 2025 disclosures revealing $43M revenue decrease and $57.5M EBITDA cut, causing 33.81% stock decline. Shareholders can join by March 9.

Pomerantz Law Firm files class action lawsuit against Varonis Systems for securities fraud following a 63.9% revenue decline and 48.67% stock drop.

Pomerantz files class action lawsuit against Bath & Body Works for alleged securities violations following missed earnings and stock decline in 2025.

Vistagen faces class action lawsuit after Phase 3 trial failure for anxiety drug. Stock plunged 80%. Investors must act by March 16, 2026 deadline.